GLOBAL GENERAL SURGERY DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

The global general surgery devices market size is expected to reach US$ 30.33 Bn by 2030, from US$ 16.46 Bn in 2023, exhibiting a CAGR of 9.1% during the forecast period.

General surgery devices can be broadly categorized into surgical sutures, staplers, hand instruments, emergency care devices, and electrosurgical devices. Surgical sutures include absorbable and non-absorbable sutures used to hold tissue together during surgical wound closure. Staplers are automated devices used as an alternative to sutures for wound closure as they require less time and expertise. Common hand instruments used in general surgeries are scalpels, forceps, retractors and suction devices to facilitate internal examination and procedures.

Global General Surgery Devices Market- Regional Insights

• North America is expected to be the largest market for general surgery devices during the forecast period, accounting for over 35.7% of the market share in 2023. North America continues to dominate the global general surgery devices market owing to presence of major market players and well-developed healthcare infrastructure in the region. The US accounts for the largest market share in North America due to supportive healthcare policies and rising awareness about advanced surgical treatments among population. Moreover, hospitals are well-equipped with advanced surgical devices that perform complex surgeries efficiently. Strong focus on innovation and technological advancements has ensured continuous development of innovative devices with improved functionality. Devices manufacturers also get quick approvals and launches of new devices in the market, which help maintain the leader position of the region. However, pricing pressures from insurance companies and regulatory authorities have led to adoption of cost-effective import devices from other regions.
• Asia Pacific market is expected to be the second-largest market for general surgery devices market, accounting for over 25.2% of the market share in 2023. Asia Pacific region has emerged as the fastest growing market for general surgery devices globally. The growth can be attributed to rapidly developing healthcare infrastructure, growing medical tourism industry and rising healthcare expenditures in emerging economies like China and India. Rapid economic growth has improved access to advanced surgical treatments for larger population base. In addition, growing geriatric population suffering from chronic diseases demand effective surgical care. Industry presence of global players is also strengthening through partnerships, acquisitions and entry of low-cost Devices. Countries like China and India also have skilled workforce for manufacture of affordable devices. This has provided boost to regional exports while satisfying domestic demand. Governments also promote local manufacturing through initiatives to reduce imports. Overall increasing investments by both public and private players to avail surgical facilities will continue driving the Asia Pacific market during forecast period.
• Europe market is expected to be the fastest-growing market for general surgery devices market, with a share of 19% during the forecast period. The growth of the market in Europe is attributed to the increasing prevalence of cardiovascular disease in the region.

Analyst View: The global general surgery devices market is expected to witness steady growth over the coming years. The increasing volume of general surgical procedures being performed globally will be a major driver. Higher incidence of conditions like obesity, appendicitis and hernia is leading to higher surgical interventions. Adoption of minimally invasive techniques is also growing which will boost procurement of general surgery devices. However, budgetary constraints in price sensitive markets may limit demand to some extent.

North America currently dominates the market owing to well-developed healthcare systems and faster uptake of advanced devices. However, Asia Pacific is likely to emerge as the fastest growing regional market. This can be attributed to improving access to healthcare, growing medical tourism industry and rising disposable incomes in developing nations like India and China. Manufacturers are also shifting their focus towards these emerging economies.

Figure 1. Global General Surgery Devices Market Share (%), By Region, 2023

To learn more about this report, request sample copy

Global General Surgery Devices Market- Drivers

• Rapid aging of global population: As life expectancy continues to rise across the world, the proportion of elderly people in the population is growing significantly. Older individuals are more likely to develop various medical conditions that require surgical treatment. Age-related disorders like cardiovascular diseases, cancers, respiratory diseases and others contribute greatly to the rising disease burden. The needs of geriatric patients also pose unique challenges due to age-related physiological changes and higher risk of complications during and after surgery. This growing senior demographic is poised to significantly drive the demand for various general surgery devices and equipment designed to handle age-related complexities. Procedures involving hip, knee and joint replacements as well as treatment of gastrointestinal conditions are expected to rise sharply. Device manufacturers will need to focus on developing senior-friendly products, simplify surgical techniques and offer specialized training to cater to this important patient subset.
• Rise of lifestyle disease and chronic conditions: Modern lifestyles characterized by sedentary routines, unhealthy diets and urbanization have led to steep increases in non-communicable or lifestyle diseases all over the world. Conditions like diabetes, obesity and their associated co-morbidities have emerged as leading causes of disease burden. The growing prevalence of these chronic illnesses is intimately linked to the metabolic and dietary shifts occuring globally. Their management often involves surgical interventions at various stages of progression. For instance, bariatric surgery volumes are bound to rise in sync with obesity epidemics worldwide. Similarly, diabetic foot complications, cardiovascular problems and certain cancers occurring disproportionately in diabetics will drive the need for various associated general surgical procedures. Device companies need to proactively create awareness and work with public health stakeholders to curb risk factors driving the silent pandemic of chronic diseases.
• Growth in minimally invasive surgeries: The global market for minimally invasive surgeries (MIS) has been experiencing significant growth over the past few years. This growth is attributed to several factors, which include the following:
  • Technological Advancements: Innovation in medical technology has made MIS more accessible and effective. New tools and improved imaging techniques allow surgeons to perform procedures with greater precision and control.
  • Patient Preference: MIS typically results in smaller incisions, reduced pain, shorter hospital stays, quicker recovery times, and minimal scarring, which makes it a preferred choice for many patients.
  • Rising Healthcare Costs: Minimally invasive surgeries can often help reduce overall healthcare costs by shortening hospital stays and reducing the time needed for recovery compared to traditional open surgeries.

Thus, the increasing number of minimally invasive surgeries globally is a significant factor propelling the growth of the market over the forecast period

For instance, according to an article published by the Journal of Global Health in December 2022, there is a large unmet need for surgical intervention in South and Southeast Asia with 5,627 cases per 100,000 population, second only to Africa. An estimated 3.72 billion people are at risk of catastrophic health expenditures (CHEs) as a result of surgery, with sub-Saharan Africa and Southeast Asia being disproportionately affected.

Similarly, according to a report published in the National Center for Biotechnology Information, the total number of minimally invasive neurosurgery procedures performed in the U.S. was approximately 52,949 in 2022

Global General Surgery Devices Market- Opportunities

• Investment in R&D of innovative devices: investment in Research and Development (R&D) of innovative devices is a critical driver for growth and advancement. Companies operating in this space are continually investing in R&D to improve existing technologies and to innovate new products that can cater to the evolving needs of the healthcare sector. Here are some key points that highlight the significance of R&D investment in the general surgery devices market:
  • Development of Advanced Surgical Instruments: Enhanced Instrumentation: R&D efforts are leading to the development of more precise and versatile surgical instruments, such as robotics-assisted devices, which provide greater accuracy and flexibility in MIS procedures.
  • Customized Solutions: Tailoring devices to specific surgical procedures can improve outcomes and patient safety.
  • Improved Visualization Techniques: High-definition Imaging: Investments in R&D are improving the quality of imaging techniques, which is vital for the success of MIS.
  • Real-time Monitoring: Innovation is focusing on equipment that allows real-time monitoring of vital statistics and surgical progress.
• Rising Healthcare Expenditure: One of the significant factors influencing the growth rate of the global general surgery devices market is the growing healthcare expenditure, which helps in improving its infrastructure. For instance, according to the International Health Care System of the U.S., in June 2020, U.S. government organizations aim to improve the healthcare infrastructure by increasing funding, setting legislation and national strategies, and cofounding and setting basic requirements and regulations for the Medicaid program. Similarly, in November 2022, the Canadian Institute for Health Information reported that the total health spending in Canada was US$ 331 billion in 2022, or US$ 8,563 per Canadian, while health expenditure represented 12.2% of Canada's gross domestic product (GDP) in 2022, following a high of 13.8% in 2020.
• Technological advancements: Technological advancements are key factors fueling the growth of the minimally invasive surgeries (MIS) market globally. Here's a summary of the most significant advancements that are driving the market:
• Robotic Surgery: Robotic systems, such as the da Vinci Surgical System, provide surgeons with an unparalleled level of precision and control, leading to better outcomes for patients. These systems are continually being improved with better sensors, more dexterous instruments, and more intuitive controls.
• Enhanced Imaging Technologies: Advances in imaging, including 3D visualization and real-time navigation using intraoperative MRI or CT scans, have improved the surgeon's ability to operate with precision and to verify the success of the procedure as its happening.
• High-definition Cameras and Monitors: These have significantly improved the visualization of the surgical field, making MIS safer and more effective.
• Single-incision Laparoscopic Surgery (SILS): This technique involves using flexible instruments and cameras that can be inserted through a single point, leading to even less postoperative pain and scarring than traditional laparoscopic techniques.
• Natural Orifice Transluminal Endoscopic Surgery (NOTES): NOTES is a newer technique that involves passing flexible surgical tools and an endoscope through natural orifices like the mouth or vagina to reach the abdominal cavity.

Global General Surgery Devices Market- Trends

• Demand for Advanced Diagnostic Tools Drives Growth in Imaging Segment: In terms of imaging modalities, the General Surgery Devices Market is segmented into X-ray, endoscopy, ultrasound, and other imaging modalities. Among these segments, endoscopy contributes the highest share of the market owning to advancements in minimally invasive surgical techniques.
  • Endoscopy devices have seen widespread adoption among general surgeons due to advantages such as reduced trauma to patients, shorter recovery times, and improved clinical outcomes. Manufacturers are introducing novel endoscopy solutions such as high definition and 3D imaging technologies to provide surgeons with clearer visuals during complex procedures. Capsule endoscopy has also gained ground as it allows examination of parts of the gastrointestinal tract that are difficult to visualize with standard endoscopes.
  • Demand for less invasive diagnostic tools is expected to bode well for ultrasound segment. Portable ultrasound scanners are finding increasing usage in outpatient and ambulatory settings for real-time guidance during surgeries. Technology advancements including higher frequencies transducers and volumetric imaging modes have made ultrasound a useful companion for general surgery applications ranging from biopsy to vascular access.
  • X-ray continues to be a mainstream diagnostic modality. However, radiation over-exposure concerns may limit the segment's potential. On the other hand, hybrid operating rooms integrating advanced imaging capabilities are opening new opportunities for assisted navigation during surgical interventions.
• Advanced Wound Care Products Spur Growth in Therapeutic Devices Category: In terms of product categories, the General Surgery Devices Market is segmented into surgical sutures & staples, handheld surgical equipment, electrosurgical devices, and other therapeutic devices. Among these segments, therapeutic devices contribute the highest share due to rising incidence of chronic wounds and increasing adoption of advanced wound management solutions.
  • Chronic and hard-to-heal wounds place a significant burden on healthcare systems worldwide. In response, manufacturers are developing novel wound dressings infused with antimicrobial agents, growth factors, and other compounds that accelerate the healing process. Biomaterials that integrate tissue regeneration and infection management are gaining ground. Negative pressure wound therapy systems utilizing vacuum-assisted closure technology have emerged as an important therapeutic option for complex surgical wounds.
  • Rising rates of lifestyle diseases like diabetes have parallelly driven demand for wound care products. Effective wound management helps prevent serious complications and associated healthcare expenditures in these patient groups. Additionally, home healthcare providers are increasingly relying on advanced wound management solutions to deliver cost-efficient post-surgery care. This expansion of therapeutic resources in the postoperative continuum bodes well for the overall segment.

Global General Surgery Devices Market - Restraints

• Stringent regulatory approval process: one important factor that medical device companies must navigate is the stringent regulatory approval process. This process ensures that new surgical devices are safe and effective before they reach the market, but it can also be complex and time-consuming, potentially impacting the time-to-market for new innovations. Here’s how the approval process is affecting the market:
  • Market Entry Delays: The rigorous testing and validation required by regulatory bodies like the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and others can lead to delays in the introduction of new devices into the market.
  • Research and Development Challenges: Companies must invest heavily in R&D to meet high regulatory standards which can result in increased upfront costs and longer development timelines.
  • Clinical Trials: Conducting comprehensive clinical trials to demonstrate the safety and efficacy of MIS devices is a significant part of the approval process and can be both costly and time-intensive.
  • Documentation and Record-Keeping: Maintaining detailed records to comply with regulations like ISO 13485 for medical devices requires sophisticated management systems and can add to operational overhead.
• High cost of advanced devices: The side effects of Nicotine Replacement Therapy (NRT) products influence consumer preferences and usage patterns within the global NRT market. While NRT is widely regarded as a safer alternative to smoking, the products can still have side effects, which need to be considered by healthcare providers and patients alike

Figure 2. Global General Surgery Devices Market Share (%), By Type, 2023

To learn more about this report, request sample copy

Global General Surgery Devices Market- Recent Developments

Product Launch

• On February 7, 2023, OSSIO, Inc., a fast-growing orthopedic fixation technology company, announced the launch of the new OSSIOfiber Compression Staple, the next step towards becoming the gold standard in orthopedic fixation. OSSIO’s fifth product family, OSSIOfiber Compression Staples, allow surgeons to evolve to stronger, bio-integrative compression.
• In September 2022, Olympus Corporation, a medical device company, announced the launch of VISERA ELITE III, its newest surgical visualization platform that addresses the needs of healthcare professionals (HCPs) for endoscopic procedures across multiple medical disciplines. VISERA ELITE III offers various imaging functions, all supported in one system enabling minimally invasive therapies such as Laparoscopic Colectomy and Laparoscopic Cholecystectomy.
• In December 2020, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic, a medical device company, announced the launch of EEA Circular Stapler with Tri-Staple Technology - the first 3-row Circular Stapler with varied height staples. The new Tri-Staple Technology comprises a sloped cartridge face that delivers less stress on tissue. It also offers consistent performance over a broad range of tissue thickness and allows for greater perfusion into the staple line 1,2,3,4,5.

The EEA circular stapler with Tri-Staple technology is designed to work in harmony with the natural properties of the tissue before, during, and after stapling

Business Development Activities by the Market Players

• On July 14, 2023, TELA Bio, Inc., a commercial medical device company, announced a three-year dual-source agreement known biosynthesis to one of the national purchasing groups (GPO). The agreement, which runs through January 1, 2026, provides significant growth opportunities over the term of the contract and provides GPO members with access to significant cost savings and clinical differentiation.
• On January 5, 2023, Organon, a global women’s healthcare company, announced a strategic investment in Claria Medical, Inc. a privately-held company developing an investigational medical device being studied for use during minimally invasive laparoscopic hysterectomy. The agreement also grants Organon the option to acquire Claria Medical.
• In August 2022, Standard Bariatrics, Inc., a surgical medical device company, announced that they had signed a definitive agreement to be acquired by Teleflex Incorporated, a leading global provider of medical technologies designed to improve the health and quality of people’s lives

Top companies in Global General Surgery Devices Market

• Medtronic Plc
• Johnson & Johnson Service; Inc.
• Conmed Corporation
• Integra LifeSciences
• Smith & Nephew
• Becton; Dickinson and Company (Bd)
• Braun Melsungen Ag
• Cadence Inc
• Integer Holdings Corporation
• Olympus Corporation
• Stryker
• Boston Scientific Corporation
• Erbe Elektromedizin Gmbh
• 3M Healthcare

Definition: General surgery devices include a wide range of instruments used for a variety of procedures such as gastrointestinal surgeries, cardiac surgeries, wound care, and others. These devices are designed to perform specific tasks like cutting, dissecting, grasping, suturing, and stapling during surgical procedures.